Nevro to Announce Preliminary Second Quarter Worldwide Revenue, Discuss Full Year 2018 Revenue Guidance and Provide Business Updates

REDWOOD CITY, Calif., July 13, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that its management will be hosting a business update conference call before market open beginning at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time) on Monday, July 16, 2018. 

Investors interested in listening to the conference call may do so by dialing (866) 393-4306 for U.S. callers or (734) 385-2616 for international callers (Conference ID: 2196519), or logging into the webcast on the "Investors" section of the Company's website at www.nevro.com/investors. Following the call, a replay will be available on the Investor Events and Presentations webpage of the Company's website.

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Senza® system and Senza II™ system are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.

Investor Relations Contact:
Nevro Investor Relations
(650) 433-3247
ir@nevro.com

View original content with multimedia:http://www.prnewswire.com/news-releases/nevro-to-announce-preliminary-second-quarter-worldwide-revenue-discuss-full-year-2018-revenue-guidance-and-provide-business-updates-300680880.html

SOURCE Nevro Corp.